Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV). Journal:Journal of Clinical Oncology | 1-Jun-2024 |